Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email or phone (03) 9662 9420.

Please click the heading in the left hand column to access consultation information from the relevant website.

Consultation Details

National Clinical Quality Registry Strategy

Due: 20 June


Clinical Quality Registers (CQRs) monitor the appropriateness and effectiveness of health care by routinely collecting and analysing clinical performance data.

The draft National CQR Strategy aims to drive continuous improvements in the quality and value of health care to achieve better health outcomes for all Australians. They can also be very valuable sources of data for research.

 The draft Strategy was developed by the Australian and state/territory governments, under the auspices of the Australian Health Ministers’ Advisory Council (AHMAC). It has now been released for consultation.

Commercialising Business Ideas

Due: 26 June


In 2018, The Department of Industry Innovation and Science conducted consultations to understand the needs of innovative Australian Small and Medium Enterprises (SMEs) seeking to commercialise their business ideas. These consultations focused on intellectual capital, an important source of growth for SMEs.

The Department is now seeking feedback on the findings of these consultations to help inform policies to address the issues identified.

Emerging treatments- regulation

Due: 30 June

The Medical Practitioners Board is consulting on the regulation of medical practitioners who provide complementary and unconventional medicine and emerging treatments. While excluding treatments in clinical trials, it includes treatments like stem cells, where unproven treatments are marketed and undertaken by medical practitioners. A consultation paper is available from the website.

Primary Care Data Asset

Due: 30 June (Extended)

The AIHW is developing a Primary Care Data Asset to support the reporting of key primary health care indicators, resulting in a better understanding of patient outcomes, from diagnosis, treatment and experiences within the healthcare system.

It is recently concluded a targeted consultation and has now opened a public consultation process, seeking electronic submissions. The Due date for submissions has been extended to 30 June.